Literature DB >> 6426082

Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions.

I Juhan-Vague, B Moerman, F De Cock, M F Aillaud, D Collen.   

Abstract

Rapid inhibition of tissue-type plasminogen activator (t-PA) in human plasma was measured by addition of 5 IU (50 ng) of purified t-PA per ml plasma and measurement of residual t-PA in the euglobulin precipitate after 5 min incubation at 37 degrees C. The recovery of both t-PA activity and t-PA related antigen in pooled plasma from healthy individuals was approximately 90 percent, indicating that one ml of pooled normal plasma inhibits less than 1 IU or 10 ng of t-PA within 5 min. Of 20 control subjects 13 had less than 1 IU inhibitor activity; 5 subjects inhibited between 1 and 3 IU of t-PA and 2 subjects inhibited around 4.5 IU. The inhibitor titer in the latter two had however decreased to 1.8 and 2.7 IU after two days. Markedly increased rapid inhibition of t-PA (greater than 4 IU per ml) was found in plasma of patients with severe liver disease (3 of 8), pancreatitis (4 of 8), malignancy (5 of 26), but only very occasionally and transiently in that of patients with myocardial infarction (5 of 28) or deep vein thrombosis (2 of 9). Increased inhibition was observed on the first day following coronary bypass (22 of 42) or open heart (16 of 27) surgery but this had disappeared in 15 of 16 patients on the fifth postoperative day. Titration of inhibitor levels revealed maximal amounts of 30 to 50 IU per ml plasma.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6426082     DOI: 10.1016/0049-3848(84)90018-5

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  29 in total

1.  Regulation of airway and alveolar epithelial cell apoptosis by p53-Induced plasminogen activator inhibitor-1 during cigarette smoke exposure injury.

Authors:  Shwetha K Shetty; Yashodhar P Bhandary; Amarnath S Marudamuthu; Daniel Abernathy; Thirunavukkarasu Velusamy; Barry Starcher; Sreerama Shetty
Journal:  Am J Respir Cell Mol Biol       Date:  2012-05-16       Impact factor: 6.914

2.  Plasminogen activators in human colorectal neoplasia.

Authors:  J S Gelister; M Mahmoud; M R Lewin; P J Gaffney; P B Boulos
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-20

3.  Distribution of plasminogen activator inhibitor (PAI-1) in tissues.

Authors:  A J Simpson; N A Booth; N R Moore; B Bennett
Journal:  J Clin Pathol       Date:  1991-02       Impact factor: 3.411

Review 4.  Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions.

Authors:  Matteo Cesari; Marco Pahor; Raffaele Antonelli Incalzi
Journal:  Cardiovasc Ther       Date:  2010-07-07       Impact factor: 3.023

5.  Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived components.

Authors:  M Colucci; J A Paramo; J M Stassen; D Collen
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

6.  Plasminogen activator inhibitor in the blood of patients with coronary artery disease.

Authors:  J A Paramo; M Colucci; D Collen; F van de Werf
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-31

7.  Platelet release protein which inhibits plasminogen activators.

Authors:  N A Booth; J A Anderson; B Bennett
Journal:  J Clin Pathol       Date:  1985-07       Impact factor: 3.411

8.  Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice.

Authors:  F Samad; D J Loskutoff
Journal:  Mol Med       Date:  1996-09       Impact factor: 6.354

9.  p53- and PAI-1-mediated induction of C-X-C chemokines and CXCR2: importance in pulmonary inflammation due to cigarette smoke exposure.

Authors:  Nivedita Tiwari; Amarnath S Marudamuthu; Yoshikazu Tsukasaki; Mitsuo Ikebe; Jian Fu; Sreerama Shetty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-08       Impact factor: 5.464

10.  Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells.

Authors:  T D Gelehrter; R Sznycer-Laszuk
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.